After its founding in 1989, NeuroSearch A/S (NEUR.CO) was the first Danish biotech to go public in 1996, raising 100 million Euros. Today the company is headquartered in the busy Medicon Valley, a center of Danish Biotech, and has over 200 employees. The company currently has seven compounds in clinical development. It has research collaborations with Abbott (ABT) and GlaxoSmithKline (GSK), in addition to its own in-house development programs…
